Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1669 News Items found 13 Years of Storytelling: MSK’s Visible Ink Writing Program Presents Performances of Works by Patients Wednesday, March 23, 2022 For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry. FDA Approves Promising Therapy for Advanced Prostate Cancer: Targets a Protein Called PSMA Wednesday, March 23, 2022 A new treatment approved by the FDA could be a game changer for men with advanced prostate cancer. New Gastric & Esophageal Cancer Treatment Breakthrough Wednesday, March 23, 2022 There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments. Two Sloan Kettering Institute Researchers Named 2022 Kravis Women in Science Endeavor (WiSE) Fellowship Grant Recipients Wednesday, March 23, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients. Watch: MSK Experts Share Tips for Healthy Eating and Explore the Connection Between Diet and Cancer Wednesday, March 23, 2022 MSK recognized National Cancer Prevention Month (February) and National Nutrition Month (March) with online educational programming highlighting the connection between diet, nutrition, and cancer. SKI Scientists Determine Structure of a DNA Damage 'First Responder' Monday, March 21, 2022 The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works. Q&A Meet Charles Swanton, a Recipient of the Paul Marks Prize for Cancer Research Thursday, March 17, 2022 Charles Swanton of Cancer Research UK and University College London was one of the recipients of the 2021 Paul Marks Prize for Cancer Research. Atefeh Riazi Named 2022 Healthcare Information and Management Systems Society (HIMSS) Most Influential Women in Health IT Award Recipient Monday, March 14, 2022 Atefeh “Atti” Riazi, Senior Vice President and Chief Information Officer of Memorial Sloan Kettering Cancer Center (MSK) has been selected as a recipient of the 2022 Health Information and Management System Society (HIMSS) Most Influential Women in Health IT Awards. How Do Gut Microbes Affect the Success of CAR T Immunotherapy? New Answers From MSK Monday, March 14, 2022 In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy. Inflammatory Breast Cancer: The Disease That Starts With a Rash on the Breast Thursday, March 10, 2022 Learn about Memorial Sloan Kettering's expertise in inflammatory breast cancer. Q&A Meet Sun Hur, a Recipient of the Paul Marks Prize for Cancer Research Thursday, March 10, 2022 Sun Hur of Harvard Medical School and Boston Children’s Hospital was one of the recipients of the 2021 Paul Marks Prize for Cancer Research. MSK’s Second Opinion Spared Joe Ryan From Grueling Therapy for Esophageal Cancer Thursday, March 10, 2022 A former teacher and volunteer firefighter benefits from less-intense treatment for early stage-esophageal cancer. How Does an At-Home Colorectal Cancer Screening Test Compare to a Colonoscopy? Answers From an Expert at Memorial Sloan Kettering Cancer Center Wednesday, March 9, 2022 Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center. SKI Scientists Discover a New Twist on an 80-Year-Old Biochemical Pathway Wednesday, March 9, 2022 With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought. Dr. Carol Brown Discusses Health Equity at White House, ASCO Events Tuesday, March 8, 2022 Chief Health Equity Officer Carol Brown shared information about cancer health equity during two expert panels in February. Karen Granville Believes in Paying it Forward for Women’s History Month Tuesday, March 8, 2022 Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment. Sex and Cancer: What Men Should Know Thursday, March 3, 2022 Dr. Diane Reidy-Lagunes speaks with Dr. John Mulhall, Director of the Male Sexual and Reproductive Medicine Program at MSK and editor-in-chief of The Journal of Sexual Medicine, to discuss the impacts of cancer and its treatment on men’s sexual health. Charles Washington: Doing the Right Thing Monday, February 28, 2022 Charles Washington, Senior Director of Hospital Administration in Radiation Oncology, was born and raised in Detroit, Michigan. In 1967, when he was in... Q&A Meet Ralph DeBerardinis, a Recipient of the Paul Marks Prize for Cancer Research Monday, February 28, 2022 Ralph DeBerardinis, a professor at the University of Texas Southwestern, was one of the recipients of the 2021 Paul Marks Prize for Cancer Research. Finding What Causes Resistance to Leukemia Drug Pirtobrutinib? MSK Researchers Investigate Thursday, February 24, 2022 In a study published in the New England Journal of Medicine (NEJM), an MSK team report that they have found what enables cancer cells to become resistant to the experimental drug pirtobrutinib. 12 13 14 15 16 17 18 19 20 Book traversal links for Newsroom Previous Newsroom Next MSK Experts Present Research at Bone Marrow Transplant and Cellular Therapy Meeting